Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,868,835 |
|
|||||
| News | - | ||||||
| Day High | 24.25 | Low High |
|||||
| Day Low | 23.96 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Alkermes PLC | ALKS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.02 | 0.08% | 24.02 | 18:08:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 23.98 | 23.96 | 24.25 | 24.02 | 24.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 22,434 | 1,868,835 | $ 24.12 | $ 45,077,018 | - | 22.01 - 33.71 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:46:19 | 2 | $ 24.01 | USD |
Alkermes PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.01B | 167.08M | - | 1.66B | 355.76M | 2.13 | 11.28 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alkermes News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALKS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.54 | 24.84 | 23.86 | 24.21 | 1,474,242 | -0.52 | -2.12% |
| 1 Month | 24.55 | 25.285 | 23.26 | 24.28 | 1,564,118 | -0.53 | -2.16% |
| 3 Months | 29.77 | 30.41 | 23.26 | 26.15 | 1,846,072 | -5.75 | -19.31% |
| 6 Months | 24.48 | 32.88 | 22.22 | 27.07 | 2,183,247 | -0.46 | -1.88% |
| 1 Year | 29.78 | 33.71 | 22.01 | 27.56 | 1,957,685 | -5.76 | -19.34% |
| 3 Years | 22.35 | 33.71 | 21.24 | 26.87 | 1,635,297 | 1.67 | 7.47% |
| 5 Years | 23.68 | 33.71 | 11.98 | 24.04 | 1,555,689 | 0.34 | 1.44% |
Alkermes Description
| Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. |
